232 related articles for article (PubMed ID: 16236550)
1. The clinical immunology of human Chagas disease.
Dutra WO; Rocha MO; Teixeira MM
Trends Parasitol; 2005 Dec; 21(12):581-7. PubMed ID: 16236550
[TBL] [Abstract][Full Text] [Related]
2. The importance of aberrant T-cell responses in Chagas disease.
DosReis GA; Freire-de-Lima CG; Nunes MP; Lopes MF
Trends Parasitol; 2005 May; 21(5):237-43. PubMed ID: 15837613
[TBL] [Abstract][Full Text] [Related]
3. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
[TBL] [Abstract][Full Text] [Related]
4. Host cell invasion by Trypanosoma cruzi: a unique strategy that promotes persistence.
Fernandes MC; Andrews NW
FEMS Microbiol Rev; 2012 May; 36(3):734-47. PubMed ID: 22339763
[TBL] [Abstract][Full Text] [Related]
5. Disease Tolerance and Pathogen Resistance Genes May Underlie
Chevillard C; Nunes JPS; Frade AF; Almeida RR; Pandey RP; Nascimento MS; Kalil J; Cunha-Neto E
Front Immunol; 2018; 9():2791. PubMed ID: 30559742
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of Chagas' disease.
Andrade ZA
Res Immunol; 1991 Feb; 142(2):126-9. PubMed ID: 1907753
[No Abstract] [Full Text] [Related]
7. Role of Trypanosoma cruzi autoreactive T cells in the generation of cardiac pathology.
Gironès N; Carrasco-Marin E; Cuervo H; Guerrero NA; Sanoja C; John S; Flores-Herráez R; Fernández-Prieto L; Chico-Calero I; Salgado H; Carrión J; Fresno M
Ann N Y Acad Sci; 2007 Jun; 1107():434-44. PubMed ID: 17804572
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in immunoregulation and pathology of human Chagas disease.
Dutra WO; Gollob KJ
Curr Opin Infect Dis; 2008 Jun; 21(3):287-92. PubMed ID: 18448974
[TBL] [Abstract][Full Text] [Related]
9. Innate and acquired immunity in the pathogenesis of Chagas disease.
Golgher D; Gazzinelli RT
Autoimmunity; 2004 Aug; 37(5):399-409. PubMed ID: 15621564
[TBL] [Abstract][Full Text] [Related]
10. Effects of repetitive stress during the acute phase of Trypanosoma cruzi infection on chronic Chagas' disease in rats.
Caetano LC; Brazão V; Filipin Mdel V; Santello FH; Caetano LN; Toldo MP; Caldeira JC; do Prado JC
Stress; 2009 Mar; 12(2):144-51. PubMed ID: 18850489
[TBL] [Abstract][Full Text] [Related]
11. [Chagas disease. Importance of the parasite in the pathogenesis of the cardiac chronic disease].
Higuchi ML
Arq Bras Cardiol; 1995 Mar; 64(3):251-4. PubMed ID: 7487514
[No Abstract] [Full Text] [Related]
12. Mechanisms of myocardial damage in Trypanosoma cruzi infection.
Andrade ZA
Ciba Found Symp; 1983; 99():214-33. PubMed ID: 6416769
[TBL] [Abstract][Full Text] [Related]
13. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease.
Zhang L; Tarleton RL
J Infect Dis; 1999 Aug; 180(2):480-6. PubMed ID: 10395865
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of Chagas heart disease: role of autoimmunity.
Engman DM; Leon JS
Acta Trop; 2002 Feb; 81(2):123-32. PubMed ID: 11801219
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology of Trypanosoma cruzi infection and Chagas's disease.
Hudson L
Trans R Soc Trop Med Hyg; 1981; 75(4):493-8. PubMed ID: 6798723
[No Abstract] [Full Text] [Related]
16. The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.
Pellegrini A; Guiñazu N; Giordanengo L; Cano RC; Gea S
Future Microbiol; 2011 Dec; 6(12):1521-33. PubMed ID: 22122446
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory mechanisms in Chagas disease: modulation of apoptosis in T-cell mediated immune responses.
Chaves AT; de Assis Silva Gomes Estanislau J; Fiuza JA; Carvalho AT; Ferreira KS; Fares RC; Guimarães PH; de Souza Fagundes EM; Morato MJ; Fujiwara RT; da Costa Rocha MO; Correa-Oliveira R
BMC Infect Dis; 2016 Apr; 16():191. PubMed ID: 27138039
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
[TBL] [Abstract][Full Text] [Related]
20. Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research.
Scharfstein J; Gomes Jde A; Correa-Oliveira R
Mem Inst Oswaldo Cruz; 2009 Jul; 104 Suppl 1():187-98. PubMed ID: 19753474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
